跳至主要内容
临床试验/NCT03080623
NCT03080623已完成不适用

Ultrasound-based Diagnostic Model for Differentiating Malignant Breast Lesion From Benign Lesion

Peking University4 个研究点 分布在 1 个国家目标入组 1,981 人开始时间: 2018年9月8日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
1,981
试验地点
4
主要终点
two breast ultrasound identified benign lesion

研究概览

简要总结

This study proposed to construct an ultrasound-based diagnostic model for Differentiating Malignant Breast Lesion From Benign Lesion. This study contains both retrospective and prospective part, which are designed for model construction and independent validation, respectively.This study aims to construct an easy-to-use ultrasound-based model, prove the efficacy of the model for identifying malignant breast lesion from benign lesion, and finally promote the application of this diagnostic model in more clinics.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • with single breast lesion(maximum diameter>0.8 cm)
  • agree to receive follow-up in six months and take the second breast ultrasound six month after the first breast ultrasound, if a benign diagnosis is achieved at the first ultrasound
  • sign the informed consent

排除标准

  • lost to follow-up
  • failed to take the second breast ultrasound six month after the first breast ultrasound

结局指标

主要结局

two breast ultrasound identified benign lesion

时间窗: between first detection of breast lesion and the second ultrasound(six month)

for patients regarded as benign by the breast ultrasound, they will receive a second breast ultrasound after six month(this is regular examination for patients with first detected breast lesion). If the second ultrasound indicates benign, the lesion will be regarded as benign

breast biopsy proved malignant or benign lesion

时间窗: between breast ultrasound and biopsy(one week)

for patients regarded as malignant by the breast ultrasound, breast biopsy results are used as reference test, which determines the breast lesion is malignant or benign

次要结局

未报告次要终点

研究者

发起方
Peking University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Tao OUYANG

Chairman of Breast Center of Beijing Cancer Hospital

Peking University

研究点 (4)

Loading locations...

相似试验